Read More Analyst Ratings News Price Target Piper Sandler Maintains Underweight on Tyson Foods, Lowers Price Target to $79 By Benzinga Newsdesk July 1, 6:39 AM Piper Sandler analyst Michael Lavery maintains Tyson Foods (NYSE:TSN) with a Underweight and lowers the price target from $85 to $79. TSN
Read More Analyst Ratings Management Media News Penny Stocks Tech Rolls Royce Names This PE Partner As New Chief From January; Analysts Give Thumbs Up By Anusuya Lahiri July 26, 7:51 AM Rolls Royce Holdings plc (OTC:RYCEY) named Tufan Erginbilgic, a private equity partner and former BP plc (NYSE:BP) executive, to succeed Warren… BP
Read More Biotech FDA General News enVVeno Medical Successfully Passes Preliminary FDA Safety Review For The VenoValve U.S. Pivotal Study By Benzinga Newsdesk November 7, 9:46 AM The Company submitted safety data for the first 20 patients enrolled in the ongoing SAVVE U.S. pivotal study for the VenoValve Following the initial safety data review by the FDA, the SAVVE study is cleared to continue NVNO
Read More Analyst Color Analyst Ratings Asset Sales Cannabis Commodities Exclusives General Government Interview M&A Management Markets Movers & Shakers News Penny Stocks Regulations Retail Sales Small Cap Sundial, Canopy Growth And More: Analyst Examines The Race For The US Cannabis Market By Nicolas Jose Rodriguez September 10, 12:48 PM US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to ACRHF